texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x
Request an Appointment

Texas Oncology Welcomes Anna Priebe, M.D., FACOG

October 25, 2019

Texas Oncology recently welcomed Anna Priebe, M.D., FACOG, to the team. Dr. Priebe, now seeing patients in Tyler and Longview, has extensive experience in the minimally invasive management of gynecologic cancers. She is also passionate about clinical research for women with gynecologic cancer. Dr. Priebe is excited to serve patients in her home state of Texas after more than six years in Florida.

What’s the best preventative measure against gynecologic cancers?

The importance of screenings cannot be underestimated, not just for gynecologic cancers, but for all types of cancer. Maintaining a healthy lifestyle is also important. We know that excess weight greatly increases a person’s cancer risk.

When it comes to gynecologic cancer, what topic do you wish patients were more open about?

Gynecologic cancer types occur in parts of the body that are considered very personal and private. People are usually embarrassed discussing health concerns “down there,” and tend to neglect the subject. They’re either scared or shy about discussing the affected area. Being open and honest about symptoms and concerns saves lives. As physicians, we want our patients to feel comfortable discussing anything – that’s why we’re here.

In your opinion, what is the single most important breakthrough in gynecologic cancer care? 

There isn’t just one. We’re used to seeing exciting advances in other areas of oncology, such as molecular therapies and immunotherapy. But just in the past year we have seen significant developments in the treatment of gynecologic cancers through targeted therapies and the data to back up its effectiveness.

I think it’s amazing that we continue to offer patients advanced treatment options that can target their specific cancer type. Each patient’s cancer is completely different, but we are getting closer to being able to characterize what’s going on in these individual cases. I also think that the advent of minimally invasive surgery in the last 15 years has transformed the way we are able to treat patients. Rather than five-day stays, patients can go home the same day.

For upcoming webinars visit www.TexasOncologyFoundation.org.